Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on “Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57”

Luchian, Maria–Luiza; Motoc, Andreea; Lochy, Stijn; Magné, Julien; Belsack, Dries; Mey, Johan De; Roosens, Bram; Bussche, Karen Van den; Boeckstaens, Sven; Chameleva, Hadischat; Geers, Jolien; Houard, Laura; Potter, Tom De; Allard, Sabine; Weytjens, Caroline; Droogmans, Steven; Cosyns, Bernard

doi:10.3390/diagnostics12081837

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…iv) Dyspnea: Dyspnea, along with fatigue, is the most common LC-related symptom. Mechanisms of LC-related dyspnea might be multifaceted, including dysfunctional breathing with or without hyperventilation deconditioning, subclinical myocardial disease, and peripheral limitations on exercise due to microcirculatory dysfunction (45)(46)(47). Cardiopulmonary exercise testing (CPET) is commonly used to evaluate unexplained dyspnea as well as to identify the cause of dyspnea and exercise intolerance in these patients (48).…”

Section: Wwwbiosciencetrendscom Bioscience Trends Advance Publication P4mentioning

confidence: 99%

Sequelae of long COVID, known and unknown: A review of updated information

Asakawa

Cai

Shen

et al. 2023

BST

View full text Add to dashboard Cite

Over three years have passed since the COVID-19 pandemic started. The dangerousness and impact of COVID-19 should definitely not be ignored or underestimated. Other than the symptoms of acute infection, the long-term symptoms associated with SARS-CoV-2 infection, which are referred to here as "sequelae of long COVID (LC)", are also a conspicuous global public health concern. Although such sequelae were well-documented, the understanding of and insights regarding LC-related sequelae remain inadequate due to the limitations of previous studies (the follow-up, methodological flaws, heterogeneity among studies, etc.). Notably, robust evidence regarding diagnosis and treatment of certain LC sequelae remain insufficient and has been a stumbling block to better management of these patients. This awkward situation motivated us to conduct this review. Here, we comprehensively reviewed the updated information, particularly focusing on clinical issues. We attempt to provide the latest information regarding LC-related sequelae by systematically reviewing the involvement of main organ systems. We also propose paths for future exploration based on available knowledge and the authors' clinical experience. We believe that these take-home messages will be helpful to gain insights into LC and ultimately benefit clinical practice in treating LC-related sequelae.

show abstract